Skip to main content
. 2021 Oct 27;61(7):2783–2791. doi: 10.1093/rheumatology/keab790

Table 3.

Model diagnosticsa

Measure Apparent performance (95% CI)b Test performance (95% CI)c Average optimism (95% CI)d Optimism corrected performance (95% CI)e External validation (CPRD Aurum) (95% CI)
Overall calibration slope 1.00 (0.75, 1.25) 0.72 (0.50–0.94) 0.28 0.72 (0.47–0.97) 0.91 (0.74–1.07)
Royston D statistic 1.06 (0.77, 1.35) 0.90 (0.63–1.17) 0.33 0.73 (0.44–1.02) 0.97 (0.89–1.05)
R 2 0.21 (0.12, 0.30) 0.16 (0.08–0.24) 0.10 0.11 (0.02–0.20) 0.18 (0.16–0.21)
a

Results from a single imputed dataset but similar across the other imputations (data not shown).

b

Refers to performance (95% CI) estimated directly from the data that was used to develop the model.

c

Determined by executing the full model in each bootstrap sample (500 samples with replacement), calculating bootstrap performance and applying same model in the original sample.

d

Average difference between model performance in bootstrap data and test performance in the original dataset.

e

Subtracting average optimism from apparent performance.